These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19487543)

  • 81. Proteomics analysis of human breast milk to assess breast cancer risk.
    Aslebagh R; Channaveerappa D; Arcaro KF; Darie CC
    Electrophoresis; 2018 Feb; 39(4):653-665. PubMed ID: 29193311
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical mass spectrometry proteomic diagnosis by conformal predictors.
    Gammerman A; Nouretdinov I; Burford B; Chervonenkis A; Vovk V; Luo Z
    Stat Appl Genet Mol Biol; 2008; 7(2):Article13. PubMed ID: 18673293
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cancer biomarker discovery via low molecular weight serum proteome profiling - Where is the tumor?
    Davis MT; Auger P; Spahr C; Patterson SD
    Proteomics Clin Appl; 2007 Dec; 1(12):1545-58. PubMed ID: 21136654
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Longitudinal Serum Protein Analysis of Women with a High Risk of Developing Breast Cancer Reveals Large Interpatient Versus Small Intrapatient Variations: First Results from the TESTBREAST Study.
    Hagenaars SC; Dekker LJM; Ravesteijn B; van Vlierberghe RLP; Romijn FPHTM; Verhoeff L; Witkamp AJ; Schenk KE; Keymeulen KBIM; Menke-Pluijmers MBE; Dassen AE; Kortmann BA; de Vries J; Rutgers EJT; van der Burgt YEM; Meershoek-Klein Kranenbarg E; Cobbaert CM; Luider TM; Mesker WE; Tollenaar RAEM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293255
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review.
    Callesen AK; Vach W; Jørgensen PE; Cold S; Mogensen O; Kruse TA; Jensen ON; Madsen JS
    J Proteome Res; 2008 Apr; 7(4):1395-402. PubMed ID: 18303834
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Proteomic analysis of breast tissue and nipple aspirate fluid for breast cancer detection.
    Ruhlen RL; Sauter ER
    Biomark Med; 2007 Aug; 1(2):251-60. PubMed ID: 20477400
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Integrated Proteomic and N-Glycoproteomic Analyses of Human Breast Cancer.
    Wang Z; Liu H; Yan Y; Yang X; Zhang Y; Wu L
    J Proteome Res; 2020 Aug; 19(8):3499-3509. PubMed ID: 32543193
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparative profiling by data-independent acquisition mass spectrometry reveals featured plasma proteins in breast cancer: a pilot study.
    Yoon KH; Chu H; Kim H; Huh S; Kim EK; Kang UB; Shin HC
    Ann Surg Treat Res; 2024 Apr; 106(4):195-202. PubMed ID: 38586559
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A mouse model repository for cancer biomarker discovery.
    Kelly-Spratt KS; Kasarda AE; Igra M; Kemp CJ
    J Proteome Res; 2008 Aug; 7(8):3613-8. PubMed ID: 18624399
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer.
    Yeh CY; Adusumilli R; Kullolli M; Mallick P; John EM; Pitteri SJ
    Biomark Res; 2017; 5():30. PubMed ID: 29075496
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Examining the generalizability of research findings from archival data.
    Delios A; Clemente EG; Wu T; Tan H; Wang Y; Gordon M; Viganola D; Chen Z; Dreber A; Johannesson M; Pfeiffer T; ; Uhlmann EL
    Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2120377119. PubMed ID: 35858443
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
    Suzuki A; Iizuka A; Komiyama M; Takikawa M; Kume A; Tai S; Ohshita C; Kurusu A; Nakamura Y; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Akiyama Y
    Cancer Genomics Proteomics; 2010; 7(1):17-23. PubMed ID: 20181627
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study.
    Larkin SE; Johnston HE; Jackson TR; Jamieson DG; Roumeliotis TI; Mockridge CI; Michael A; Manousopoulou A; Papachristou EK; Brown MD; Clarke NW; Pandha H; Aukim-Hastie CL; Cragg MS; Garbis SD; Townsend PA
    Br J Cancer; 2016 Oct; 115(9):1078-1086. PubMed ID: 27685442
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry.
    Song D; Yue L; Zhang J; Ma S; Zhao W; Guo F; Fan Y; Yang H; Liu Q; Zhang D; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
    Cancer Biol Ther; 2016 Jun; 17(6):635-47. PubMed ID: 27260686
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry.
    Song D; Yue L; Li H; Zhang J; Yan Z; Fan Y; Yang H; Liu Q; Zhang D; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
    Br J Cancer; 2016 Apr; 114(8):929-38. PubMed ID: 27002935
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pathway-based Biomarkers for Breast Cancer in Proteomics.
    Zhang F; Deng Y; Wang M; Cui L; Drabier R
    Cancer Inform; 2014; 13(Suppl 5):101-8. PubMed ID: 25972728
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A neural network approach to multi-biomarker panel discovery by high-throughput plasma proteomics profiling of breast cancer.
    Zhang F; Chen J; Wang M; Drabier R
    BMC Proc; 2013 Dec; 7(Suppl 7):S10. PubMed ID: 24565503
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer.
    Zhang F; Wang M; Michael T; Drabier R
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S8. PubMed ID: 24565027
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Multiple biomarker panels for early detection of breast cancer in peripheral blood.
    Zhang F; Deng Y; Drabier R
    Biomed Res Int; 2013; 2013():781618. PubMed ID: 24371830
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Breast cancer subtyping from plasma proteins.
    Zhang F; Chen JY
    BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S6. PubMed ID: 23369492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.